เอกสารอ้างอิง
[1]. Bussone G. Pathophysiology of migraine. Neurol. Sci. 2004;25 Suppl 3:S239-41.
[2]. Mayans L, Walling A. Acute migraine headache: treatment strategies. Am. Fam. Physician. 2018;97(4):243-51.
[3]. Schwedt TJ. Acute treatment of migraine in adults. In: Post TW, ed. UpToDate. Waltham: UpToDate; 2022. (Accessed on January 12, 2022.)
[4]. Ha H, Gonzalez A. Migraine headache prophylaxis. Am Fam Physician. 2019;99(1):17-24.
[5]. Ondansetron. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 16 January 2022; cited 17 January 2022]. Available from: http://online.lexi.com
[6]. Ailani J, Burch RC, Robbins MS; Board of directors of the American headache society. The American headache society consensus statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039.
[7]. Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology and the American headache society. Neurology. 2019;93(11):487-499.
[8]. Ergonovine. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 16 January 2022; cited 17 January 2022]. Available from: http://online.lexi.com
[9]. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000;123(Pt 1):9-18.
[10]. Gallagher RM. Menstrual migraine and intermittent ergonovine therapy. Headache. 1989;29(6):366-7.
[11]. Talai A, Heilbrunn B. Ondansetron for acute migraine in the pediatric emergency department. Pediatr. Neurol. 2020;103:52-6.
เอกสารอ้างอิง
[1]. Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ;Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian HeadacheSociety Guideline: acute drug therapy for migraine headache. Can J. Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80.
[2]. Sharma R, Panda A. Ondansetron-induced headache in a parturient mimicking postdural puncture headache. Can J. Anaesth. 2010 Feb;57(2):187-8. doi: 10.1007/s12630-009-9226-3. Epub 2009 Dec 31. PMID: 20043218.
[3]. Singh V, Sinha A, Prakash N. Ondansetron-induced migraine-type headache. Can J. Anaesth. 2010 Sep;57(9):872-3. doi: 10.1007/s12630-010-9350-0. Epub 2010 Jul 27. PMID: 20661681.
[4]. Ergonovine. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 6 Jan 2021; cited 12 Nov 2021]. Available from: http://online.lexi.com. Subscription required to view.
[5]. Furman B. Ergometrine. In: Reference Module in Biomedical Sciences [Internet]. Elsevier; 2018. Available from: https://www.sciencedirect.com/science/article/pii/ B9780128012383980486.
[6]. Ma YZ., Qiang GF., Du GH. (2018) Ergometrine and Ergotamine. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_39.
[7]. Raskin NH, Schwartz RK. Interval therapy of migraine: long-term results. Headache. 1980 Nov;20(6):336-40. doi: 10.1111/j.1526-4610.1980.hed2006336.x. PMID: 7216754.
[8]. Gallagher RM. Menstrual migraine and intermittent ergonovine therapy. Headache. 1989 Jun;29(6):366-7. doi: 10.1111/j.1526-4610.1989.hed2906366.x. PMID: 2759844.
[9]. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000 Jan;123 (Pt 1):9-18. doi: 10.1093/brain/123.1.9. PMID: 10611116.
[10]. Ondansetron. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 6 Jan 2021; cited 12 Nov 2021]. Available from: http://online.lexi.com. Subscription required to view.
[11]. Headache Classification Subcommittee of the International Headache, Society. The International Classification of Headache disorders: 3rd edition. Cephalalgia. 2018;38:1-211.